SEHK:2096Pharmaceuticals
Simcere Pharmaceutical Group (SEHK:2096) Completes HK$2 Billion Follow-On Equity Offering
Simcere Pharmaceutical Group (SEHK:2096) recently completed a follow-on equity offering, raising HKD 1.57 billion, which coincided with a 10.69% increase in the company's share price over the past month. The acceptance of the NDA for a pioneering pediatric anti-influenza drug further highlighted the company's growth in product innovation. While these events provided a solid narrative for Simcere, the share price move was broadly in line with the general upward market trends, where major...